Background
Numerous epidemiological studies have shown the relationship between nitrogen dioxide (NO
2) and the alterations of respiratory function or asthma symptoms [USEPA, 2016]. However, conventional NO
2 assays measure nitrous acid (HONO) as NO
2 [
1]. Moreover, HONO exists in equilibrium with NO
2, nitric oxide (NO), and water (H
2O): 2HONO ⇆ NO + NO
2 + H
2O [
2].
A NO2 threshold value of 40 μg/m3 (approximately 0.02 parts per million (ppm)) was set by the WHO to protect the public from the health effects of this gas. However, it is unclear to what extent the health effects observed in epidemiological studies are attributable to NO2 itself or to the other primary and secondary combustion-related products (such as organic carbon and HONO) to which it is typically correlated [WHO Air quality guidelines 2005 global update].
HONO may be one of the causative agents underlying the relationship between NO
2 and asthma symptoms. A few inhalation studies have examined the association between HONO exposure and respiratory symptoms and lung function in mildly asthmatic adult subjects or in healthy adult nonsmokers [
3,
4]. In a few epidemiological studies, Van Strien et al. (2004) observed that HONO exposure was not independently associated with respiratory symptoms during the first year of life [
5], and Jarvis et al. (2005) observed that indoor HONO levels were associated with decreased lung function and possibly with more respiratory symptoms [
6]. In an epidemiological pilot study, we observed that indoor HONO was closely correlated with outdoor NO
2 in one research year, and indoor HONO was significantly associated with asthma attacks, according to Mann–Whitney
U test, in another year [
7].
There are various studies that have reported the HONO/NO
2 ratio. The HONO/NOx ratio in the atmosphere at a highway junction in Houston, TX, was 1.7% [
8], which was relatively high [
9]. In the epidemiological study by Jarvis et al. (2005), the median indoor concentration of HONO (3.10 ppb) was approximately one-fourth that of NO
2 (12.76 ppb), and the maximum indoor concentration of HONO (20.55 ppb) was approximately one-third that of NO
2 (59.12 ppb) [
6]. In our epidemiological pilot study, the median concentration of indoor HONO (4.70 ppb) during the weeks with mild asthma attacks was approximately 28% that of indoor NO
2 (16.69 ppb), and approximately 36% that of outdoor NO
2 (13.23 ppb) [
7]. Incidentally, the median concentration of indoor NO during the weeks with mild asthma attacks was 4.29 ppb, and that of outdoor NO was 1.56 ppb. In addition, the median concentration of indoor HONO (2.81 ppb) during the weeks without mild asthma attacks was approximately 17% that of indoor NO
2 (16.07 ppb), and approximately 24% that of outdoor NO
2 (11.69 ppb). The median concentration of indoor NO during the weeks without mild asthma attacks was 5.47 ppb, and that of outdoor NO was 1.62 ppb.
We investigated the biological effects of HONO not only in an epidemiological pilot study [
7] but also in animal exposure experiments [
10‐
12]. We observed pulmonary emphysema-like alterations in the alveolar duct centriacinar regions of guinea pigs after exposure to 3.6 ppm HONO [
10]; a significant increase in baseline pulmonary resistance (RLung), alveolar mean linear intercept (Lm), thickness of bronchial connective tissue near the hilar, and Muc5ac expression after 5.8 ppm HONO exposure in rats [
12]; and hyperplasia of the terminal bronchial epithelial cells, with an irregular meandering and absence of dysplasia after the exposure of mice to 8.4 ppm HONO [
11].
The effects of NO
2 on RLung have not been previously reported. Sulfur dioxide (SO
2) exposure is known to impair RLung in rats. Shore et al. (1995) reported that exposure to 250 ppm SO
2 caused a small but significant increase in RLung and a decrease in dynamic lung compliance (Cdyn), suggesting lung fibrosis [
13]. Although both NO
2 and SO
2 cause pulmonary emphysema-like alterations, these alterations are always accompanied by fibrosis. In contrast, HONO causes pulmonary emphysema-like alterations and an increase in baseline RLung, but not fibrosis or inflammatory changes. For example, exposure of rats to 5.8 ppm HONO did not affect baseline Cdyn or expression of chemokine (C-X-C motif) ligand 1 and tumor necrosis factor alpha [
12]. Pulmonary fibrosis is rare in asthmatic patients. Therefore, HONO may impact human respiratory function more than either NO
2 or SO
2 alone.
We showed that pulmonary emphysema-like alterations due to HONO varied with the animal species [
10‐
12]. After exposure to HONO, the effect of pulmonary emphysema-like alterations was observed most notably in guinea pigs [
10] but not in mice [
11]. Therefore, guinea pigs seemed to be the most suitable animals for observation of the histological effects of HONO.
This study aimed to investigate the dose-response effects of HONO exposure associated with histopathological alterations in the respiratory tracts of guinea pigs to find the lowest observed adverse effect level (LOAEL) of HONO. Animal exposure experiments for NO
2 are frequently conducted at concentrations of around 20 ppm [
14‐
16]. Therefore, based on the HONO/NO
2 ratio obtained in the epidemiological study, our first HONO exposure experiment in animals was conducted using a HONO concentration of 3.6 ppm, and we observed clear histopathological alterations. Therefore, the HONO concentrations used in this study were established on the basis of reduction by a geometric series starting from the half concentration used in the first HONO exposure experiment.
Methods
Animals
Male Hartley guinea pigs (
n = 20; body weight, approximately 360 g; age, 6 weeks) were purchased from SLC, Japan (Shizuoka, Japan). The animals were divided into four groups (
n =5/group) and preliminarily housed for 1 week in individual animal-exposure chamber with filtered room air [
10]. Briefly, the animals were raised in 0.2 m
3 hand-made acrylic chambers with a 16 L/min flow volume of filtrated room air, using about 5 kg charcoal activated granular, 15 sheets of American air filters for vinyl isolator (Clea Japan, Inc., Tokyo, Japan), air compressors (0.4LE-8S; Hitachi Industrial Equipment Systems Co., Ltd., Tokyo, Japan), dehumidifiers (RAX3F; Orion Machinery Co., Ltd., Nagano, Japan), high-pressure regulator valves (with the largest supply pressure of about 0.078 MPa; model no. 44–2263-241; Kojima Instruments Inc., Kyoto, Japan) and mass flow controllers to control air flow (model 8350MC-0-1-1; Kojima Instruments Inc.). The internal pressure in the chambers was adjusted to about + 1 mm H
2O relative to atmospheric pressure. Food and water were available freely during all experimental periods. The animal room was maintained under a dynamic temperature of 25 ± 2 °C to stabilize the chamber temperature and humidity. The room lighting was turned on/off by staff at 9:00 and 17:30.
HONO exposure
In the animal-exposure chambers, the guinea pigs were exposed to filtered room air (control group: C group) or filtered room air after passing through three HONO-generation systems (low-, middle-, and high-concentration groups: L group, M group, and H group) [
17]. Briefly, the HONO-generation system was based on spraying a mixture of aqueous sodium nitrite solution (> 98.5% pure sodium nitrite; Wako Pure Chemical Industries, Ltd.) and aqueous acid solution (85–92% lactic acid; Wako Pure Chemical Industries, Ltd.) in a porous polytetrafluoroethylene tube (TB-1008, approximately 15 cm length; Sumitomo Electric Fine Polymer, INC., Osaka, Japan) using filtered room air through an atomizer-nozzle (BN90s-IS[V], SUS316L, 1/8PT, M14; Atomax Co., Shizuoka, Japan). The filtered room air passing through three HONO-generation systems flowed into three HONO-exposure chambers. The aqueous solution inside the tube of HONO generation systems was discharged with a small portion of the gas. The HONO concentrations in the animal-exposure chambers were regulated based on the concentration of the aqueous sodium nitrite solution (L, M, and H groups: 2, 6, and 18 mmol/L). Guinea pigs were continuously exposed to HONO for 4 weeks. HONO exposure was stopped for approximately 3 h once every week to allow for the exchange of cages and cleaning of chambers.
Measurement of nitrogen oxides
The HONO-measurement system has been described previously [
10]. Briefly, we used a sampling method of HONO, employing two Harvard EPA Annular Denuders (URG-2000-30 × 150-3CSS; URG Corporation, NC) in the series sampling [
18,
19]. The annular denuders were coated with sodium carbonate and glycerol. Air from each chamber was sampled for 30 min per day for 5 days per week with an air flow of 1 L/min, using NOx analyzer. The concentration of HONO in the air of each chamber was measured after the end of the exposure experiment, using the denuder extract with milliQ by ion chromatography (700 series; Metrohm Japan LTD., Tokyo, Japan).
The concentrations of the contaminated NO2 and NO were measured by a NOx analyzer (ECL-77A; J-science, Inc., Kyoto, Japan) after passing into the sodium carbonate annular denuders.
Histopathological analysis
All animals were sacrificed after 4 weeks of HONO exposure using an overdose of pentobarbital sodium and exsanguination. For light microscopy, lung tissue samples of three guinea pigs were fixed with 10% neutral-buffered formalin (Mildform 10 NM; Wako Pure Chemical Industries, Ltd.) at 20 cm/H
2O for the alveolar distension in each group. The lung samples were embedded in paraffin. Tissues were then sectioned and deparaffinized, stained with hematoxylin and eosin (HE) and Elastica van Gieson (EVG), and examined under a light microscope. The Lm, a measure of airspace enlargement, was examined [
12]. Using light microscopy images, Lm was determined using the transparent overlay tracing of a 0.1-mm mesh hemocytometer. All intercepts with alveolar septal walls were counted at the intersection point of around five non-adjacent meshes that did not intercept bronchus or blood vessels. The total length (2 mm) of all the lines combined divided by the total number of intercepts yielded the Lm for the region studied [
20,
21]. The thickness of the bronchial smooth muscle layer near the middle of the bronchus was measured using right-lung middle lobe samples. Using light microscopy, the thickness of the bronchial smooth muscle layer of each guinea pig was determined at five points around one bronchus [
12].
For transmission electron microscopy (TEM) and scanning electron microscopy (SEM), lung tissue samples of two guinea pigs were fixed with 1% paraformaldehyde electron microscopy grade (TAAB Laboratories Equipment, Ltd., Berkshire, England) and 1% glutaraldehyde (20% glutaraldehyde solution; Wako Pure Chemical Industries, Ltd.) phosphate buffer at 20 cm/H2O for the alveolar distension in each group. The tissues were treated by routine methods and examined under TEM (JEM-1200 EX; JEOL Ltd., Tokyo, Japan) and SEM (JSM-T100; JEOL Ltd).
Statistical analysis
Relationships between HONO-exposure concentrations and the alterations of body weight, Lm, and thickness of the bronchial smooth muscle layer were examined for statistical significance using the analysis of variance (ANOVA), followed by Dunnett’s multiple comparison. Differences associated with p values of < 0.05 were considered significant.
Discussion
To the best of our knowledge, this is the first study on exposure of animals to HONO that examined pulmonary pathological alterations using SEM and TEM images. The SEM observations confirmed pulmonary emphysema-like alterations in the centriacinar regions of alveolar ducts, which were also observed under light microscopy in our previous HONO exposure experiments [
10]. The SEM observations suggest that HONO exposure contracts the peripheral alveoli and expands the alveolar duct lumen. Although the pulmonary emphysema-like alterations were significant only in the H group (based on Lm measurement), alterations were also observed in the L and M groups using SEM. The TEM images showed the presence of smooth muscle cells in the interstitium of alveolar duct regions in the HONO-exposure groups and confirmed that there were no injurious effects of HONO exposure, such as edematous alterations.
In our previous HONO exposure experiments in animals, secondary products of NO
2 and NO were sometimes present in the generated HONO, and the histopathological alterations that could be confirmed differed depending on the animal species [
10‐
12]. This experiment had the lowest concentration of HONO in our HONO exposure experiments so far; NO
2 (secondary product) was not detected, and pulmonary emphysema-like alterations and a tendency for hyperplasia and pseudostratification of bronchial epithelial cells were observed. In the previous HONO exposure experiments, pulmonary emphysema-like alterations were observed in guinea pigs and rats but not in mice. Although bronchial smooth muscle hypertrophy was identified in a previous HONO exposure experiment in rats, mice had few bronchial smooth muscle cells. Therefore, we speculated that HONO might induce architectural alterations in the smooth muscle cells. In contrast, the hyperplasia of the terminal bronchial epithelial cells was remarkable in mice after exposure to the highest concentration of HONO in our HONO exposure experiments so far. A tendency for hyperplasia and pseudostratification of bronchial epithelial cells was observed in this experiment. The present results suggest that these alterations were due to HONO.
In the present study, we observed pulmonary emphysema-like alterations in the centriacinar regions of alveolar ducts along with a significant increase in Lm in the H group, tendency for hyperplasia and pseudostratification of bronchial epithelial cells, and extension of bronchial epithelial cells and smooth muscle cells in alveolar duct regions. These results had a dose-dependent tendency. These histopathological results suggest that the LOAEL of HONO is < 0.1 ppm.
LOAEL is one of the important grounds of environmental quality standards (EQSs) for hazardous air pollutants. A review for EQSs with guideline values for air pollutants, including NO
2 was reported. Although the review did not describe the LOAEL of NO
2 from animal exposure experiments, it reported that the epidemiological effects observed in residents showed a lower value than findings from animal exposure experiments and reports on human exposure. It could be that the uncertainty factor (safety factor) was not necessary because the standards were based on data obtained from human subjects, including those with high susceptibility [
22]. The EQS for NO
2 was set as follows in 1978 in Japan: “the daily average for hourly values shall be within the 0.04–0.06 ppm zone or below that zone.” The EQS for NO
2 is similar to the LOAEL of HONO exposure experiments in animals. The results from the present study suggest that HONO, which is detected as NO
2, affects human health more than NO
2 and that it is necessary to examine the involvement of HONO in the epidemiological studies of NO
2.
The existence of HONO in the atmosphere [
23] and HONO contamination in NO
2 measurements [
1] are known factors. However, the EQS for NO
2 and the measurement method of NO
2 have not been revised since 1978, and the WHO air quality guidelines state that it seems reasonable to retain an annual average limit for NO
2. The reason may be that previous studies on the health effects of HONO were not sufficient for determining the EQS for HONO. Yoshida (1988) retrospectively reported the actual procedure for setting EQSs of classical pollutants, including NO
2 [
24]. In the report, the findings from animal experiments, reports on human exposure, and epidemiological studies were collected, and the dose-effect/dose-response relationship was investigated. Generally, the most important data were the epidemiological findings. There are few studies on the health effects of HONO, and two studies on human inhalation [
3,
4], tree animal exposure studies [
10‐
12], and three epidemiological studies [
5‐
7], including our pilot study [
7], have been reported. The review of EQS for NO
2 states that scientists are in charge of proposing a guideline using scientific data, and the government is responsible for establishing its own standard. Therefore, scientists should propose a guideline for HONO, and the government should establish the EQS for HONO.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.